GE HealthCare wins FDA, CE mark approval for Allia Moveo

GE HealthCare wins FDA, CE mark approval for Allia Moveo

An animated rendering of the Allia Moveo platform. [Image from GE HealthCare] GE HealthCare (Nasdaq: GEHC)…

Continue Reading
GE HealthCare wins FDA clearance for Allia Moveo interventional imaging system

GE HealthCare wins FDA clearance for Allia Moveo interventional imaging system

GE HealthCare has received U.S. Food and Drug Administration 510(k) clearance and CE Marking for Allia…

Continue Reading
GE HealthCare gains US-EU approval for Allia Moveo imaging system

GE HealthCare gains US-EU approval for Allia Moveo imaging system

GE HealthCare CEO Peter Arduini recently said during a presentation at the J.P. Morgan Healthcare conference…

Continue Reading
GE Healthcare’s Allia Moveo Platform Receives FDA Clearance, CE Mark

GE Healthcare’s Allia Moveo Platform Receives FDA Clearance, CE Mark

Feb. 2, 2026 — GE HealthCare has announced that Allia Moveo has received U.S. Food and Drug…

Continue Reading
GE HealthCare’s Allia Moveo gains FDA and CE mark approvals

GE HealthCare’s Allia Moveo gains FDA and CE mark approvals

GE HealthCare’s Allia Moveo system GE HealthCare has announced that its Allia Moveo image-guidance platform has…

Continue Reading